Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Children's Hospital of Philadelphia
Philadelphia, United States
University of Manchester
Manchester, United Kingdom
Royal Manchester Children's Hospital
Manchester, United Kingdom
Great Ormond Street Hospital
London, United Kingdom
University of Exeter
Exeter, United Kingdom
Cook Children's Medical Center
Fort Worth, United States
University of Pennsylvania
Philadelphia, United States
Düsseldorf University Hospital
Düsseldorf, Germany
Alder Hey Children's Hospital
Liverpool, United Kingdom
University of Eastern Finland
Kuopio, Finland
References
References (62)
- 1
Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.
Tran C, Konstantopoulou V, Mecjia M, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(7-8)):873-6.
PMID: 25781533 - 2
Hyperinsulinemic Hypoglycemia.
Güemes M, Hussain K
Pediatric clinics of North America 2015; (62(4)):1017-36.
PMID: 26210630 - 3
Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children.
Ferrara C, Patel P, Becker S, et al.
The Journal of pediatrics 2016; (168()):212-219 doi:10.1016/j.jpeds.2015.09.045.
PMID: 26490124 - 4
A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA).
Fang C, Ding X, Huang Y, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(3)):385-8.
PMID: 26656609 - 5
Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.
Stanley CA
The Journal of clinical endocrinology and metabolism 2016; (101(3)):815-26 doi:10.1210/jc.2015-3651.
PMID: 26908106 - 6
Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.
Ninković D, Sarnavka V, Bašnec A, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(9)):1083-8.
PMID: 27383869 - 7
Robust regulation of hepatic pericentral amination by glutamate dehydrogenase kinetics.
Bera S, Lamba S, Rashid M, et al.
Integrative biology : quantitative biosciences from nano to macro 2016; (8(11)):1126-1132 doi:10.1039/c6ib00158k.
PMID: 27747338 - 8
A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase.
Barrosse-Antle M, Su C, Chen P, et al.
Pediatric diabetes 2017; (18(8)):911-916 doi:10.1111/pedi.12507.
PMID: 28165182 - 9
Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia.
Sakakibara A, Hashimoto Y, Kawakita R, et al.
Pediatric diabetes 2018; (19(2)):259-264 doi:10.1111/pedi.12548.
PMID: 28597971 - 10
Seizures and diagnostic difficulties in hyperinsulinism-hyperammonemia syndrome.
Aka S, Alanay Y, Boodhansingh KE, et al.
The Turkish journal of pediatrics 2016; (58(5)):541-544.
PMID: 28621098 - 11
Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
Timlin MR, Black AB, Delaney HM, et al.
Pediatric cardiology 2017; (38(6)):1247-1250 doi:10.1007/s00246-017-1652-3.
PMID: 28642988 - 12
Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry.
Hosokawa Y, Kawakita R, Yokoya S, et al.
Endocrine journal 2017; (64(9)):867-880 doi:10.1507/endocrj.EJ17-0024.
PMID: 28701683 - 13
Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study.
Helleskov A, Melikyan M, Globa E, et al.
Frontiers in endocrinology 2017; (8()):156 doi:10.3389/fendo.2017.00156.
PMID: 28740482 - 14
Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
Grimaldi M, Karaca M, Latini L, et al.
Human molecular genetics 2017; (26(18)):3453-3465 doi:10.1093/hmg/ddx213.
PMID: 28911206 - 15
Glutamate dehydrogenase: role in regulating metabolism and insulin release in pancreatic β-cells.
Wilson DF, Cember ATJ, Matschinsky FM
Journal of applied physiology (Bethesda, Md. : 1985) 2018; (125(2)):419-428 doi:10.1152/japplphysiol.01077.2017.
PMID: 29648519 - 16
Safety and effectiveness, including intelligence prognosis, of diazoxide in pediatric patients with hyperinsulinemic hypoglycemia: special survey in Japan (long-term, all-case survey).
Fukutomi M, Shimodera M, Maeda Y, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2018; (27(3)):131-143 doi:10.1297/cpe.27.131.
PMID: 30083030 - 17
The effect of hypoglycaemia on neurocognitive outcome in children and adolescents with transient or persistent congenital hyperinsulinism.
Muukkonen L, Männistö J, Jääskeläinen J, et al.
Developmental medicine and child neurology 2019; (61(4)):451-457 doi:10.1111/dmcn.14039.
PMID: 30246438 - 18
Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
Herrera A, Vajravelu ME, Givler S, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(12)):4365-4372 doi:10.1210/jc.2018-01613.
PMID: 30247666 - 19
Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.
Su C, Liang XJ, Li WJ, et al.
Journal of diabetes research 2018; (2018()):2802540 doi:10.1155/2018/2802540.
PMID: 30306091 - 20
The Effect of Continuous Intravenous Glucagon on Glucose Requirements in Infants with Congenital Hyperinsulinism.
Hawkes CP, Lado JJ, Givler S, De Leon DD
JIMD reports 2019; (45()):45-50 doi:10.1007/8904_2018_140.
PMID: 30311139 - 21
Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.
Strajnar A, Tansek MZ, Podkrajsek KT, et al.
Balkan journal of medical genetics : BJMG 2018; (21(1)):77-81 doi:10.2478/bjmg-2018-0014.
PMID: 30425915 - 22
Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Roy K, Satapathy AK, Houhton JAL, et al.
Indian journal of pediatrics 2019; (86(11)):1051-1053 doi:10.1007/s12098-019-02980-x.
PMID: 31119523 - 23
Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
Chen SC, Dastamani A, Pintus D, et al.
Clinical endocrinology 2019; (91(6)):770-775 doi:10.1111/cen.14096.
PMID: 31520536 - 24
Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase.
Luczkowska K, Stekelenburg C, Sloan-Béna F, et al.
Human genomics 2020; (14(1)):9 doi:10.1186/s40246-020-00262-8.
PMID: 32143698 - 25
Continuous Glucose Monitoring Systems: Are They Useful for Evaluating Glycemic Control in Children with Hyperinsulinism?
Rayannavar A, Elci OU, Mitteer L, De León DD
Hormone research in paediatrics 2019; (92(5)):319-327 doi:10.1159/000506230.
PMID: 32208390 - 26
Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution.
Brandt A, Agarwal N, Giri D, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(5)):675-679.
PMID: 32229669 - 27
Pericardial Effusion Associated with Diazoxide Treatment for Congenital Hyperinsulinism.
Hastings LA, Preddy J, McCready M, et al.
Hormone research in paediatrics 2020; (93(3)):206-211 doi:10.1159/000507624.
PMID: 32580193 - 28
Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series.
Salomon-Estebanez M, Yau D, Dunne MJ, et al.
Frontiers in endocrinology 2020; (11()):441 doi:10.3389/fendo.2020.00441.
PMID: 33013678 - 29
Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
Garg PK, Putegnat B, Truong L, et al.
PloS one 2020; (15(10)):e0241243 doi:10.1371/journal.pone.0241243.
PMID: 33108363 - 30
Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism.
Roeper M, Salimi Dafsari R, Hoermann H, et al.
Frontiers in endocrinology 2020; (11()):580642 doi:10.3389/fendo.2020.580642.
PMID: 33424766 - 31
Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.
Chen X, Feng L, Yao H, et al.
PloS one 2021; (16(2)):e0246463 doi:10.1371/journal.pone.0246463.
PMID: 33571197 - 32
A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism.
Siersbæk J, Larsen AR, Nybo M, Christesen HT
Frontiers in endocrinology 2020; (11()):614993 doi:10.3389/fendo.2020.614993.
PMID: 33679602 - 33
Congenital Hyperinsulinism.
Sims K
NeoReviews 2021; (22(4)):e230-e240 doi:10.1542/neo.22-4-e230.
PMID: 33795398 - 34
18F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital Hyperinsulinism.
States LJ, Davis JC, Hamel SM, et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(Suppl 2)):51S-56S doi:10.2967/jnumed.120.246033.
PMID: 34230074 - 35
PNC2 (SLC25A36) Deficiency Associated With the Hyperinsulinism/Hyperammonemia Syndrome.
Shahroor MA, Lasorsa FM, Porcelli V, et al.
The Journal of clinical endocrinology and metabolism 2022; (107(5)):1346-1356 doi:10.1210/clinem/dgab932.
PMID: 34971397 - 36
Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families.
Banerjee I, Raskin J, Arnoux JB, et al.
Orphanet journal of rare diseases 2022; (17(1)):61 doi:10.1186/s13023-022-02214-y.
PMID: 35183224 - 37
Anxiety, depression, and quality of life in parents of children with congenital hyperinsulinism.
Roeper M, Hoermann H, Salimi Dafsari R, et al.
European journal of pediatrics 2022; (181(7)):2779-2788 doi:10.1007/s00431-022-04486-9.
PMID: 35507217 - 38
Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism.
Raskin J, Pasquini TLS, Bose S, et al.
Frontiers in endocrinology 2022; (13()):886552 doi:10.3389/fendo.2022.886552.
PMID: 35573986 - 39
Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome.
Rosenfeld E, Nanga RPR, Lucas A, et al.
Orphanet journal of rare diseases 2022; (17(1)):248 doi:10.1186/s13023-022-02398-3.
PMID: 35752848 - 40
Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease.
Hewat TI, Johnson MB, Flanagan SE
Frontiers in endocrinology 2022; (13()):873254 doi:10.3389/fendo.2022.873254.
PMID: 35872984 - 41
Families' Experiences of Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A Thematic Analysis.
Auckburally SH, Worth C, Salomon-Estebanez M, et al.
Frontiers in endocrinology 2022; (13()):894559 doi:10.3389/fendo.2022.894559.
PMID: 35928891 - 42
Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1.
Aftab S, Gubaeva D, Houghton JAL, et al.
Endocrine connections 2023; (12(4)).
PMID: 35951311 - 43
Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome.
Boodhansingh KE, Rosenfeld E, Lord K, et al.
Hormone research in paediatrics 2022; (95(5)):492-498 doi:10.1159/000526203.
PMID: 35952631 - 44
Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques.
Martino M, Sartorelli J, Gragnaniello V, Burlina A
Frontiers in pediatrics 2022; (10()):901338 doi:10.3389/fped.2022.901338.
PMID: 36210928 - 45
Congenital Hyperinsulinaemic Hypoglycaemia-A Review and Case Presentation.
Krawczyk S, Urbanska K, Biel N, et al.
Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206020.
PMID: 36294341 - 46
The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism.
Worth C, Dunne MJ, Salomon-Estebanez M, et al.
Frontiers in endocrinology 2022; (13()):1016072 doi:10.3389/fendo.2022.1016072.
PMID: 36407313 - 47
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
De Los Santos-La Torre MA, Del Águila-Villar CM, Lu-de Lama LR, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):207-211 doi:10.1515/jpem-2022-0490.
PMID: 36476334 - 48
The behaviour change behind a successful pilot of hypoglycaemia reduction with HYPO-CHEAT.
Worth C, Nutter PW, Salomon-Estebanez M, et al.
Digital health 2023; (9()):20552076231192011 doi:10.1177/20552076231192011.
PMID: 37545627 - 49
Congenital Hyperinsulinism - Notes for the General Pediatrician.
Estebanez MS, Worth C, Banerjee I
Indian pediatrics 2024; (61(6)):578-584.
PMID: 38584412 - 50
Octreotide efficacy and safety in children with hyperinsulinism: evidence from two Chinese centers.
Ni J, Cao B, Zeng H, et al.
European journal of pediatrics 2024; (184(1)):33 doi:10.1007/s00431-024-05884-x.
PMID: 39565408 - 51
Reverse Phenotyping: Addressing Refractory Seizures From an Endocrine Perspective.
Sherin S, Soodhana D, Mohanlal S, Pachat D
Cureus 2024; (16(12)):e75146 doi:10.7759/cureus.75146.
PMID: 39759686 - 52
Large copy number variants are an important cause of congenital hyperinsulinism that should be screened for during routine testing.
Flanagan SE, Lazaridi IA, Männistö JME, et al.
Frontiers in endocrinology 2025; (16()):1514916 doi:10.3389/fendo.2025.1514916.
PMID: 40041288 - 53
Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK.
Couch H, Pearson A, Malhotra N, et al.
The Journal of clinical endocrinology and metabolism 2025; (111(1)):139-148 doi:10.1210/clinem/dgaf313.
PMID: 40418653 - 54
Case Report: Food-based enteral formula in the nutritional management of children with hyperinsulinism: single center retrospective case series.
O'Connor G, Cheng L, Cunjamalay A
Frontiers in endocrinology 2025; (16()):1574093 doi:10.3389/fendo.2025.1574093.
PMID: 41079202 - 55
Trisomy 13 as a risk factor for pulmonary hypertension induced by diazoxide.
Ishikawa K, Nakao H, Shinjo D, et al.
Annals of pediatric cardiology 2025; (18(4)):351-356 doi:10.4103/apc.apc_65_25.
PMID: 41725869 - 56
Comprehensive genetic rescreening improves diagnostic yield in congenital hyperinsulinism.
Männistö JME, Houghton JAL, Bennett JJ, et al.
Journal of the Endocrine Society 2026; (10(4)):bvag047 doi:10.1210/jendso/bvag047.
PMID: 41924297 - 57
Natural History of the Hyperinsulinism/Hyperammonemia Syndrome: A Retrospective Review Incorporating Patient-Centered Data.
Rosenfeld E, Taylor O, Mitteer LM, et al.
Hormone research in paediatrics 2026; 1-11 doi:10.1159/000551535.
PMID: 41980002 - 58
From standard to individualized diazoxide therapy in congenital hyperinsulinism: a narrative review.
Wong T, Chan D, Chua C, et al.
Frontiers in pharmacology 2026; (17()):1781424 doi:10.3389/fphar.2026.1781424.
PMID: 41982675 - 59
Low-level mosaic variants causing the pancreatic disease congenital hyperinsulinism can be detected from blood DNA.
Bennett JJ, Laver TW, Männistö JME, et al.
EBioMedicine 2026; (128()):106308 doi:10.1016/j.ebiom.2026.106308.
PMID: 42184599 - 60
Real-world insights into neurodevelopmental outcomes amongst people with congenital hyperinsulinism.
Lopez LN, Banerjee I, De Leon DD, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42399951 - 61
Inpatient continuous glucose monitoring halves the risk of hypoglycemia in patients with hyperinsulinism.
Chandra C, De Silva S, Worthington S, et al.
Frontiers in endocrinology 2026; (17()):1943475 doi:10.3389/fendo.2026.1943475.
PMID: 42959150 - 62
Parent experiences of infant feeding in congenital hyperinsulinism: a thematic analysis.
Worthington S, Ginbey E, Otabor O, et al.
Frontiers in endocrinology 2026; (17()):1955679 doi:10.3389/fendo.2026.1955679.
PMID: 42978621